- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Ion Exchange (India) reports Q1 FY27 consolidated operating income of ₹700.5 Cr, up 20.1% YoY. However, operating EBITDA declined 49.3% to ₹31.8 Cr, with PAT plunging 93.6% to ₹3.1 Cr, impacted by higher EPC contract costs, slow UP contract execution, Roha facility costs, and the West Asia crisis. The company holds a total order book of ₹2,473 Cr and a bid pipeline of ₹9,777 Cr. Management focuses on international market strengthening, Roha plant volume ramp-up, and growth in Industrial Products, Lifecycle Services, and Specialty Chemicals.